Relationships between the plasma homocysteine levels and the polymorphisms of its metabolic enzymes and the cerebral infarction

Chinese Journal of Neurology

Volumn 36, Issue 5, 2003, Pages 359-362

  Zhang, Cheng Guo ^a   Shao, Yan ^b   Hu, Xue Qiang ^b   Cui, Jin Huan ^b  

^a THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

^b NONE

Author keywords

Brain infarction; Cystathionine beta synthase; Homocysteine; Oxidoreductases; Polymorphism (genetics)

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CREATININE; CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE;

ADULT; AGED; ALLELE; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 0346257994     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Eikelboom JW, Hankey GJ, Anand SS, et al. Association between high homocyst (e) ine and ischemic stroke due to large- and smallartery disease but not other etiologic subtypes of ischemic stroke. Stroke, 2000, 31: 1069-1075.
2. Masser PA, Taylor LM Jr, Porter JM. Importance of elevated plasma homocysteine levels as a risk factor for atherosclerosis. Ann Thorac Surg, 1994, 58: 1240-1246.
3. Tsai MY, Hanson NQ, Schwichtenberg K, et al. Amplification refractory mutation system to identify mutations in cystathionine β-synthase deficiency. Clin Chem, 1995, 41: 1775-1777.
4. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 1995, 10: 111-113.
5. Malinow MR, Nieto FJ, Szklo M, et al. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults: the atherosclerosis risk in communities study. Circulation, 1993, 87: 1107-1113.
6. Masser PA, Taylor LM Jr, Porter JM. Importance of elevated plasma homocysteine levels as a risk factor for atherosclerosis. Ann Thorac Surg, 1994, 58: 1240-1246.
7. Brattstrom L, Wilcken DEL, Ohrvik J, et al. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease. The result of a meta-analysis. Circulation, 1998, 98: 2520-2526.
8. Deloughery TG, Evans A, Sadeghi A, et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation, 1996, 94: 3074-3078.
9. Kluijtmans LAJ, Vandenheuvel LPWJ, Boers GHJ, et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet, 1996, 58: 35-41.